EXEL
Exelixis Inc
NASDAQ: EXEL · HEALTHCARE · BIOTECHNOLOGY
$44.69
-0.53% today
Updated 2026-04-29
Market cap
$11.35B
P/E ratio
16.08
P/S ratio
4.89x
EPS (TTM)
$2.78
Dividend yield
—
52W range
$34 – $50
Volume
2.7M
Exelixis Inc (EXEL) Insider transactions
Net insider activity
Net selling (913,297 shares)
Buy transactions
33
Sell transactions
67
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-26 | SENNER, CHRISTOPHER J. | EVP and CFO | Buy | 52,018 | — | — |
| 2026-02-26 | MORRISSEY, MICHAEL | Director, President and CEO | Buy | 160,437 | — | — |
| 2026-02-26 | HEFTI, BRENDA | SVP and General Counsel | Buy | 23,119 | — | — |
| 2026-02-26 | HALEY, PATRICK J. | EVP, Commercial | Buy | 40,459 | — | — |
| 2026-02-26 | AFTAB, DANA | EVP, Research and Development | Buy | 52,018 | — | — |
| 2026-02-24 | MORRISSEY, MICHAEL | Director, President and CEO | Sale | 100,278 | — | — |
| 2026-02-24 | AFTAB, DANA | EVP, Research and Development | Sale | 47,918 | $44.50 | $2.13M |
| 2026-02-19 | AFTAB, DANA | EVP, Research and Development | Sale | 29,873 | $44.35 | $1.32M |
| 2026-02-18 | WYSZOMIERSKI, JACK L | Director | Sale | 20,634 | — | — |
| 2026-02-18 | WYSZOMIERSKI, JACK L | Director | Sale | 99,574 | $44.01 | $4.38M |
| 2026-02-18 | WYSZOMIERSKI, JACK L | Director | Buy | 20,634 | $19.77 | $407934.18 |
| 2026-02-18 | SMITH, JULIE | Director | Sale | 44,087 | — | — |
| 2026-02-18 | SMITH, JULIE | Director | Sale | 20,030 | — | — |
| 2026-02-18 | SMITH, JULIE | Director | Sale | 44,087 | $44.50 | $1.96M |
| 2026-02-18 | SMITH, JULIE | Director | Sale | 20,030 | $44.30 | $887329.00 |
| 2026-02-18 | MORRISSEY, MICHAEL | Director, President and CEO | Buy | 125,094 | — | — |
| 2026-02-18 | HEFTI, BRENDA | SVP and General Counsel | Sale | 18,669 | $44.01 | $821622.69 |
| 2026-02-17 | SMITH, JULIE | Director | Sale | 42,422 | — | — |
| 2026-02-17 | SMITH, JULIE | Director | Sale | 42,422 | $43.33 | $1.84M |
| 2026-02-17 | SENNER, CHRISTOPHER J. | EVP and CFO | Sale | 30,617 | $43.67 | $1.34M |
| 2026-02-17 | MORRISSEY, MICHAEL | Director, President and CEO | Buy | 250,736 | — | — |
| 2026-02-17 | HALEY, PATRICK J. | EVP, Commercial | Sale | 64,778 | $43.50 | $2.82M |
| 2026-02-17 | HALEY, PATRICK J. | EVP, Commercial | Sale | 3,036 | $43.84 | $133098.24 |
| 2026-02-15 | SENNER, CHRISTOPHER J. | EVP and CFO | Sale | 35,870 | $43.92 | $1.58M |
| 2026-02-15 | MORRISSEY, MICHAEL | Director, President and CEO | Sale | 120,390 | $43.92 | $5.29M |
| 2026-02-15 | HEFTI, BRENDA | SVP and General Counsel | Sale | 5,430 | $43.92 | $238485.60 |
| 2026-02-15 | HALEY, PATRICK J. | EVP, Commercial | Sale | 31,483 | $43.92 | $1.38M |
| 2026-02-15 | AFTAB, DANA | EVP, Research and Development | Sale | 26,485 | $43.92 | $1.16M |
| 2026-02-15 | AFTAB, DANA | EVP, Research and Development | Sale | 12,720 | $43.92 | $558662.40 |
| 2026-02-13 | SENNER, CHRISTOPHER J. | EVP and CFO | Sale | 34,278 | $43.00 | $1.47M |
| 2026-02-13 | OLIVER, BOB | Director | Sale | 9,088 | — | — |
| 2026-02-13 | OLIVER, BOB | Director | Sale | 21,162 | $43.90 | $929011.80 |
| 2026-02-13 | OLIVER, BOB | Director | Sale | 9,088 | $43.61 | $396327.68 |
| 2026-02-13 | MORRISSEY, MICHAEL | Director, President and CEO | Sale | 494,700 | — | — |
| 2026-02-13 | MORRISSEY, MICHAEL | Director, President and CEO | Buy | 494,700 | $21.31 | $10.54M |
| 2026-02-13 | MORRISSEY, MICHAEL | Director, President and CEO | Sale | 369,606 | $43.92 | $16.23M |
| 2026-02-13 | ECKHARDT, SUE GAIL | Director | Sale | 3,856 | $43.79 | $168854.24 |
| 2026-01-15 | SENNER, CHRISTOPHER J. | EVP and CFO | Buy | 149,474 | — | — |
| 2026-01-15 | SENNER, CHRISTOPHER J. | EVP and CFO | Sale | 40,459 | $45.23 | $1.83M |
| 2026-01-15 | MORRISSEY, MICHAEL | Director, President and CEO | Buy | 548,073 | — | — |
| 2026-01-15 | MORRISSEY, MICHAEL | Director, President and CEO | Sale | 139,524 | $45.23 | $6.31M |
| 2026-01-15 | HALEY, PATRICK J. | EVP, Commercial | Buy | 139,508 | — | — |
| 2026-01-15 | HALEY, PATRICK J. | EVP, Commercial | Sale | 32,332 | $45.23 | $1.46M |
| 2026-01-15 | AFTAB, DANA | EVP, Research and Development | Buy | 119,578 | — | — |
| 2026-01-15 | AFTAB, DANA | EVP, Research and Development | Sale | 27,254 | $45.23 | $1.23M |
| 2025-12-03 | HEFTI, BRENDA | SVP and General Counsel | Buy | 30,170 | — | — |
| 2025-11-25 | JOHNSON, DAVID EDWARD | Director | Buy | 27,532 | $43.12 | $1.19M |
| 2025-11-21 | HALEY, PATRICK J. | EVP, Commercial | Sale | 28,043 | $42.58 | $1.19M |
| 2025-11-21 | AFTAB, DANA | EVP, Research and Development | Sale | 24,000 | — | — |
| 2025-11-20 | HALEY, PATRICK J. | EVP, Commercial | Sale | 23,539 | $41.93 | $986990.27 |
| 2025-11-20 | HALEY, PATRICK J. | EVP, Commercial | Sale | 10,648 | $41.77 | $444766.96 |
| 2025-11-20 | HALEY, PATRICK J. | EVP, Commercial | Sale | 10,000 | $42.11 | $421100.00 |
| 2025-11-17 | OLIVER, BOB | Director | Sale | 1,044 | — | — |
| 2025-11-12 | PAPADOPOULOS, STELIOS | Director | Sale | 100,000 | $43.55 | $4.36M |
| 2025-11-12 | MORRISSEY, MICHAEL | Director, President and CEO | Sale | 101,548 | — | — |
| 2025-11-12 | MORRISSEY, MICHAEL | Director, President and CEO | Sale | 80,000 | — | — |
| 2025-11-11 | MORRISSEY, MICHAEL | Director, President and CEO | Sale | 160,000 | — | — |
| 2025-11-11 | BECKERLE, MARY C | Director | Sale | 5,784 | — | — |
| 2025-11-11 | BECKERLE, MARY C | Director | Sale | 18,838 | $41.90 | $789312.20 |
| 2025-11-11 | BECKERLE, MARY C | Director | Sale | 5,784 | $42.03 | $243101.52 |
| 2025-11-11 | AFTAB, DANA | EVP, Research and Development | Sale | 48,383 | $42.50 | $2.06M |
| 2025-10-08 | AFTAB, DANA | EVP, Research & Development | Buy | 50,673 | — | — |
| 2025-06-03 | WYSZOMIERSKI, JACK L | Director | Sale | 7,535 | $43.09 | $324683.15 |
| 2025-06-02 | ECKHARDT, SUE GAIL | Director | Sale | 18,834 | $42.74 | $804965.16 |
| 2025-06-02 | ECKHARDT, SUE GAIL | Director | Sale | 4 | $43.67 | $174.68 |
| 2025-05-29 | WYSZOMIERSKI, JACK L | Director | Buy | 9,812 | — | — |
| 2025-05-29 | SMITH, JULIE | Director | Buy | 9,812 | — | — |
| 2025-05-29 | POSTE, GEORGE | Director | Buy | 9,812 | — | — |
| 2025-05-29 | PAPADOPOULOS, STELIOS | Director | Buy | 9,812 | — | — |
| 2025-05-29 | OLIVER, BOB | Director | Buy | 9,812 | — | — |
| 2025-05-29 | JOHNSON, DAVID EDWARD | Director | Buy | 21,464 | — | — |
| 2025-05-29 | HEYMAN, TOMAS J. | Director | Buy | 9,812 | — | — |
| 2025-05-29 | FREIRE, MARIA C | Director | Buy | 9,812 | — | — |
| 2025-05-29 | ECKHARDT, SUE GAIL | Director | Buy | 9,812 | — | — |
| 2025-05-29 | BECKERLE, MARY C | Director | Buy | 9,812 | — | — |
| 2025-05-21 | HEYMAN, TOMAS J. | Director | Sale | 4,544 | $44.29 | $201253.76 |
| 2025-05-20 | HALEY, PATRICK J. | EVP, Commercial | Sale | 34,387 | $44.06 | $1.52M |
| 2025-05-16 | SENNER, CHRISTOPHER J. | EVP and CFO | Sale | 100,000 | — | — |
| 2025-05-16 | SENNER, CHRISTOPHER J. | EVP and CFO | Buy | 100,000 | $18.80 | $1.88M |
| 2025-05-16 | POSTE, GEORGE | Director | Sale | 20,634 | — | — |
| 2025-05-16 | POSTE, GEORGE | Director | Buy | 20,634 | $19.77 | $407934.18 |
| 2025-05-16 | PETERSON, AMY C. | EVP Prod Dev & Med Aff & CMO | Sale | 40,000 | — | — |
| 2025-05-16 | PETERSON, AMY C. | EVP Prod Dev & Med Aff & CMO | Sale | 72,776 | $45.47 | $3.31M |
| 2025-05-16 | PETERSON, AMY C. | EVP Prod Dev & Med Aff & CMO | Buy | 40,000 | $21.75 | $870000.00 |
| 2025-05-16 | MORRISSEY, MICHAEL | Director, President and CEO | Buy | 87,871 | — | — |
| 2025-05-15 | SENNER, CHRISTOPHER J. | EVP and CFO | Sale | 41,422 | $44.65 | $1.85M |
| 2025-05-15 | PETERSON, AMY C. | EVP Prod Dev & Med Aff & CMO | Sale | 8,303 | $44.65 | $370728.95 |
| 2025-05-15 | PAPADOPOULOS, STELIOS | Director | Sale | 20,634 | — | — |
| 2025-05-15 | PAPADOPOULOS, STELIOS | Director | Sale | 15,874 | — | — |
| 2025-05-15 | PAPADOPOULOS, STELIOS | Director | Buy | 20,634 | $19.77 | $407934.18 |
| 2025-05-15 | PAPADOPOULOS, STELIOS | Director | Buy | 15,874 | $20.50 | $325417.00 |
| 2025-05-15 | MORRISSEY, MICHAEL | Director, President and CEO | Sale | 104,769 | $44.65 | $4.68M |
| 2025-05-15 | HESSEKIEL, JEFFREY | EVP & General Counsel | Sale | 34,035 | $44.65 | $1.52M |
| 2025-05-15 | HESSEKIEL, JEFFREY | EVP & General Counsel | Sale | 25,000 | $46.18 | $1.15M |
| 2025-05-15 | HALEY, PATRICK J. | EVP, Commercial | Sale | 116,383 | — | — |
| 2025-05-15 | HALEY, PATRICK J. | EVP, Commercial | Buy | 116,383 | $18.80 | $2.19M |
| 2025-05-15 | HALEY, PATRICK J. | EVP, Commercial | Sale | 34,705 | $44.65 | $1.55M |
| 2025-05-15 | HALEY, PATRICK J. | EVP, Commercial | Sale | 10,000 | $46.95 | $469500.00 |
| 2025-05-15 | AFTAB, DANA | CSO/EVP Disc & Trans Research | Sale | 30,693 | $44.65 | $1.37M |
| 2025-05-14 | MORRISSEY, MICHAEL | Director, President and CEO | Sale | 308,365 | — | — |